Management of Late-presenting Patients with HIV Infection
- 1 January 2010
- journal article
- review article
- Published by SAGE Publications in Antiviral Therapy
- Vol. 15 (1_suppl) , 25-30
- https://doi.org/10.3851/imp1527
Abstract
Managing patients who present late with HIV infection is challenging. All late-presenting patients should have an individual treatment plan that encompasses both anti-retroviral therapy and, where necessary, treatment for opportunistic diseases. Timely initiation of treatment in late presenters is crucial but the optimal time to start therapy depends on many individual factors, including the presence of opportunistic infection and potential drug–drug interactions. Primary drug resistance is an important contributor to poor clinical outcomes in HIV; resistance profiling before treatment initiation is therefore recommended. The choice of initial HIV treatment should reflect patient characteristics, the results of resistance testing and the complexity of concomitant disease.Keywords
This publication has 34 references indexed in Scilit:
- Report of a European Working Group on Late Presentation with HIV Infection: Recommendations and Regional VariationAntiviral Therapy, 2010
- Definition and epidemiology of late presentation in EuropeAntiviral Therapy, 2010
- Medical and Societal Consequences of Late PresentationAntiviral Therapy, 2010
- Early Antiretroviral Therapy Reduces AIDS Progression/Death in Individuals with Acute Opportunistic Infections: A Multicenter Randomized Strategy TrialPLOS ONE, 2009
- Efficacy and safety by baseline HIV-RNA and CD4 count in treatment-naive patients treated With atazanavir/r and lopinavir/r in the CASTLE studyJournal of the International AIDS Society, 2008
- O422 Do the disadvantages of late initiation of HAART persist in patients achieving and maintaining viral load (VL) suppression for a year on HAART?Journal of the International AIDS Society, 2008
- Validation of the CNS Penetration-Effectiveness Rank for Quantifying Antiretroviral Penetration Into the Central Nervous SystemArchives of Neurology, 2008
- Clinical progression of hepatitis C virus–related chronic liver disease in human immunodeficiency virus–infected patients undergoing highly active antiretroviral therapyHepatology, 2007
- Management of advanced HIV disease: resistance, antiretroviral brain penetration and malignanciesInternational Journal Of Clinical Practice, 2006
- Remission from Kaposi's sarcoma on HAART is associated with suppression of HIV replication and is independent of protease inhibitor therapyBritish Journal of Cancer, 2006